Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jashodeep Datta

Showing results (111-120 of 140) with videos related to

Pageof 14
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 14, 2025
PET-CT-based host metabolic (PETMet) features are associated with pathologic response in gastroesophageal adenocarcinomaCharlie White, Vetri Sudar Jayaprakasam, Megan Tenet, et al.
Gastroenterology|August 10, 2022
Combined MEK and STAT3 Inhibition Uncovers Stromal Plasticity by Enriching for Cancer-Associated Fibroblasts With Mesenchymal Stem Cell-Like Features to Overcome Immunotherapy Resistance in Pancreatic CancerJashodeep Datta, Xizi Dai, Anna Bianchi, et al.
Journal of Surgical Oncology|June 1, 2021
Is there a difference in utilization of a perioperative treatment approach for gastric cancer between safety net hospitals and tertiary referral centers?Michael K Turgeon, Rachel M Lee, Jessica M Keilson, et al.
Oncoimmunology|October 10, 2015
Progressive loss of anti-HER2 CD4<sup>+</sup> T-helper type 1 response in breast tumorigenesis and the potential for immune restorationJashodeep Datta, Cinthia Rosemblit, Erik Berk, et al.
Cancer|November 2, 2025
Intersection of Black race and carbohydrate antigen 19-9 nonproduction underpins worse pathologic response to neoadjuvant therapy in pancreatic cancerMary P Martos, Erin M Dickey, Kawther Abdilleh, et al.
Annals of Surgical Oncology|July 27, 2022
Genomic Predictors of Recurrence Patterns After Complete Resection of Colorectal Liver Metastases and Adjuvant Hepatic Artery Infusion ChemotherapyRaja R Narayan, Jashodeep Datta, Debra A Goldman, et al.
Biorxiv : the Preprint Server for Biology|June 21, 2024
Activation of CREB drives acinar cells to ductal reprogramming and promotes pancreatic cancer progression in animal models of alcoholic pancreatitisSupriya Srinivasan, Siddharth Mehra, Sudhakar Jinka, et al.
Cellular and Molecular Gastroenterology and Hepatology|August 14, 2025
CREB Drives Acinar to Ductal Cells Reprogramming and Promotes Pancreatic Cancer Progression in Preclinical Models of Alcoholic PancreatitisSupriya Srinivasan, Siddharth Mehra, Sudhakar Jinka, et al.
Gut|July 4, 2023
Multivalent tyrosine kinase inhibition promotes T cell recruitment to immune-desert gastric cancers by restricting epithelial-mesenchymal transition via tumour-intrinsic IFN-γ signallingLong Long Cao, Heng Lu, Mohammed Soutto, et al.
Journal of Surgical Oncology|June 14, 2022
Diagnostic laparoscopy is underutilized in the staging of gastric adenocarcinoma regardless of hospital type: An US safety net collaborative analysisAleeza J Leder Macek, Annie Wang, Michael K Turgeon, et al.
Pageof 14

Showing results (111-120 of 140) with videos related to

Sort By:
Pageof 14
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 14, 2025
PET-CT-based host metabolic (PETMet) features are associated with pathologic response in gastroesophageal adenocarcinomaCharlie White, Vetri Sudar Jayaprakasam, Megan Tenet, et al.
Gastroenterology|August 10, 2022
Combined MEK and STAT3 Inhibition Uncovers Stromal Plasticity by Enriching for Cancer-Associated Fibroblasts With Mesenchymal Stem Cell-Like Features to Overcome Immunotherapy Resistance in Pancreatic CancerJashodeep Datta, Xizi Dai, Anna Bianchi, et al.
Journal of Surgical Oncology|June 1, 2021
Is there a difference in utilization of a perioperative treatment approach for gastric cancer between safety net hospitals and tertiary referral centers?Michael K Turgeon, Rachel M Lee, Jessica M Keilson, et al.
Oncoimmunology|October 10, 2015
Progressive loss of anti-HER2 CD4<sup>+</sup> T-helper type 1 response in breast tumorigenesis and the potential for immune restorationJashodeep Datta, Cinthia Rosemblit, Erik Berk, et al.
Cancer|November 2, 2025
Intersection of Black race and carbohydrate antigen 19-9 nonproduction underpins worse pathologic response to neoadjuvant therapy in pancreatic cancerMary P Martos, Erin M Dickey, Kawther Abdilleh, et al.
Annals of Surgical Oncology|July 27, 2022
Genomic Predictors of Recurrence Patterns After Complete Resection of Colorectal Liver Metastases and Adjuvant Hepatic Artery Infusion ChemotherapyRaja R Narayan, Jashodeep Datta, Debra A Goldman, et al.
Biorxiv : the Preprint Server for Biology|June 21, 2024
Activation of CREB drives acinar cells to ductal reprogramming and promotes pancreatic cancer progression in animal models of alcoholic pancreatitisSupriya Srinivasan, Siddharth Mehra, Sudhakar Jinka, et al.
Cellular and Molecular Gastroenterology and Hepatology|August 14, 2025
CREB Drives Acinar to Ductal Cells Reprogramming and Promotes Pancreatic Cancer Progression in Preclinical Models of Alcoholic PancreatitisSupriya Srinivasan, Siddharth Mehra, Sudhakar Jinka, et al.
Gut|July 4, 2023
Multivalent tyrosine kinase inhibition promotes T cell recruitment to immune-desert gastric cancers by restricting epithelial-mesenchymal transition via tumour-intrinsic IFN-γ signallingLong Long Cao, Heng Lu, Mohammed Soutto, et al.
Journal of Surgical Oncology|June 14, 2022
Diagnostic laparoscopy is underutilized in the staging of gastric adenocarcinoma regardless of hospital type: An US safety net collaborative analysisAleeza J Leder Macek, Annie Wang, Michael K Turgeon, et al.
Pageof 14